Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-28 4:30 pm Purchase | 2023-04-26 | 13D | Applied Therapeutics, Inc. APLT | Shendelman Shoshana | 8,075,377 13.300% | 504,542 (+6.66%) | Filing History |
| 2023-03-30 5:35 pm Sale | 2022-10-27 | 13G | Applied Therapeutics, Inc. APLT | Propel Bio Partners L.P. | 1,234,519 2.570% | -1,270,862 (-50.73%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 7,300,921 9.990% | 5,200,240 (+247.55%) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | Point72 Asset Management, L.P. | 830,000 3.200% | -1,726,976 (-67.54%) | Filing History |
| 2023-02-14 2:39 pm Purchase | 2022-10-27 | 13G | Applied Therapeutics, Inc. APLT | Propel Bio Partners L.P. | 2,505,381 5.210% | 2,505,381 (New Position) | Filing History |
| 2023-02-14 2:04 pm Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | Alyeska Investment Group L.P. | 4,805,000 9.990% | 4,805,000 (New Position) | Filing History |
| 2023-02-14 11:58 am Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | ARMISTICE CAPITAL LLC | 5,333,951 9.990% | 5,333,951 (New Position) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Applied Therapeutics, Inc. APLT | FMR LLC | 2,972,371 6.184% | 2,069,896 (+229.36%) | Filing History |
| 2023-01-30 1:03 pm Unchanged | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | FRANKLIN RESOURCES INC BEN | 4,775,484 9.900% | 0 (Unchanged) | Filing History |
| 2023-01-23 1:10 pm Purchase | 2023-01-04 | 13G | Applied Therapeutics, Inc. APLT | Knoll Capital Management LLC | 3,450,000 7.180% | 3,450,000 (New Position) | Filing History |
| 2022-10-14 3:28 pm Purchase | 2022-10-12 | 13D | Applied Therapeutics, Inc. APLT | Shendelman Shoshana | 7,570,835 14.900% | 388,279 (+5.41%) | Filing History |
| 2022-07-08 12:07 pm Purchase | 2022-06-30 | 13G | Applied Therapeutics, Inc. APLT | FRANKLIN RESOURCES INC BEN | 4,775,484 10.300% | 4,775,484 (New Position) | Filing History |
| 2022-06-29 4:00 pm Purchase | 2022-06-27 | 13G | Applied Therapeutics, Inc. APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. ARE | 13,434,054 19.900% | 10,000,000 (+291.20%) | Filing History |
| 2022-03-10 09:48 am Sale | 2022-03-09 | 13G | Applied Therapeutics, Inc. APLT | FMR LLC | 902,475 3.442% | -1,341,001 (-59.77%) | Filing History |
| 2022-02-11 4:17 pm Purchase | 2021-12-31 | 13G | Applied Therapeutics, Inc. APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. ARE | 3,434,054 13.100% | 43,478 (+1.28%) | Filing History |
| 2022-02-11 4:14 pm Purchase | 2021-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 2,100,681 8.000% | 433,856 (+26.03%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Applied Therapeutics, Inc. APLT | FMR LLC | 2,243,476 8.557% | 19,511 (+0.88%) | Filing History |
| 2022-01-28 4:33 pm Purchase | 2022-01-25 | 13D | Applied Therapeutics, Inc. APLT | Shendelman Shoshana | 7,182,556 25.000% | 528,290 (+7.94%) | Filing History |
| 2022-01-04 5:20 pm Purchase | 2022-01-03 | 13G | Applied Therapeutics, Inc. APLT | Point72 Asset Management, L.P. | 2,556,976 9.800% | 2,556,976 (New Position) | Filing History |
| 2021-04-16 4:37 pm Purchase | 2021-04-13 | 13D | Applied Therapeutics, Inc. APLT | Shendelman Shoshana | 6,654,266 23.800% | 318,209 (+5.02%) | Filing History |